Our Team

Daniel D. Von Hoff, MD, FACP

Daniel D. Von Hoff, MD, FACP

Physician in Chief and Director of Translational Research at TGen (Translational Genomics Research Institute)
Chief Scientific Officer for US Oncology and for HonorHealth’s Clinical Research Institute
Clinical Professor of Medicine, University of Arizona, Tucson, AZ

Dr. Von Hoff is currently Physician in Chief and Director of Translational Research at TGen (Translational Genomics Research Institute) in Phoenix, Arizona. He is also Chief Scientific Officer for US Oncology and for HonorHealth’s Clinical Research Institute. He is also a Clinical Professor of Medicine, University of Arizona.

Dr. Von Hoff graduated from Carroll College and received his medical degree from Columbia University College of Physicians and Surgeons. He went on to complete his internship and residency in internal medicine at the University of California, San Francisco, and a fellowship in medical oncology at the National Cancer Institute. Von Hoff became a professor in the departments of medicine and cellular and structural biology at the University of Texas Health Science Center, San Antonio. In 1989, he became the founding director of the Institute for Drug Development at the Cancer Therapy and Research Center in San Antonio and 10 years later he became the director of the cancer center and professor of medicine at the University of Arizona.

Dr. Von Hoff’s major interest is in the development of new anticancer agents, both in the clinic and in the laboratory. He and his colleagues were involved in the beginning of the development of many of the agents we now use routinely, including: mitoxantrone, fludarabine, paclitaxel, docetaxel, gemcitabine, irinotecan, nelarabine, capecitabine, lapatinib and others. At present, he and his colleagues are concentrating on the development of molecularly targeted therapies for patients with pancreatic and other advanced cancers.

Dr. Von Hoff has published more than 648 papers, 138 book chapters and over 1085 abstracts. Dr. Von Hoff received the 2010 David A. Karnofsky Memorial Award from the American Society of Clinical Oncology for his outstanding contributions to cancer research leading to significant improvement in patient care.

Dr. Von Hoff was appointed to President Bush’s National Cancer Advisory Board in 2004-2010. Dr. Von Hoff is the past President of the American Association for Cancer Research (the world’s largest cancer research organization), a Fellow of the American College of Physicians, and a member and past board member of the American Society of Clinical Oncology. Dr. Von Hoff is founder and the Editor Emeritus of Investigational New Drugs – The Journal of New Anticancer Agents; and, past Editor-in-Chief of Molecular Cancer Therapeutics. He is a co-founder of the AACR/ASCO Methods in Clinical Cancer Research Workshop. He is also proud to have been a mentor and teacher for multiple medical students, medical oncology fellows, graduate students, and post-doctoral fellows.

Management Team

Shaun R. Bagai

Shaun R. Bagai

Chief Executive Officer
Ramtin Agah, MD

Ramtin Agah, MD

Chief Medical Officer, Founder
Kamran Najmabadi

Kamran Najmabadi

Chief Technology Officer, Founder

Paul Manners

Chief Financial Officer
Imtiaz Qureshi, MD

Imtiaz Qureshi, MD

Director of Imaging

Nicole Lama

Associate Director of Clinical Research

Board of Directors

Shaun R. Bagai

Shaun R. Bagai

Chief Executive Officer
Ramtin Agah, MD

Ramtin Agah, MD

Chief Medical Officer, Founder

Advisory Board

Jacob Cynamon, MD

Jacob Cynamon, MD

Professor of Clinical Radiology, Albert Einstein College of Medicine Chief, Division of Vascular and Interventional RadiologyProgram Director, Vascular and Interventional Radiology Fellowship Program Montefiore Medical Center, Bronx, NY
Mike Pishvaian, MD, PhD

Mike Pishvaian, MD, PhD

Associate Professor, Gastrointestinal Oncologist and Co-Director, Clinical Research at the Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer University of Texas, MD Anderson Cancer Center
Peter Muscarella, MD

Peter Muscarella, MD

Director, Pancreatic Surgery General Surgery Site Director, Weiler Hospital

Associate Program Director, General Surgery Residency Training Program Montefiore Medical Center, Bronx, NY

Karyn A. Goodman, MD, MS

Karyn A. Goodman, MD, MS

Professor and Vice Chair of Clinical Research, Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai
Associate Director of Clinical Research, The Tisch Cancer Institute at Mount Sinai
Daniel D. Von Hoff, MD, FACP

Daniel D. Von Hoff, MD, FACP

Physician in Chief and Director of Translational Research at TGen (Translational Genomics Research Institute)

Chief Scientific Officer for US Oncology and for HonorHealth’s Clinical Research Institute

Clinical Professor of Medicine, University of Arizona, Tucson, AZ

Emmanuel Zervos, MD

Emmanuel Zervos, MD

Executive Director of Vidant Cancer Care Chief, Division of Surgical Oncology, East Carolina University Greenville, NC
Reza Malek, MD, MSc

Reza Malek, MD, MSc

Neurointerventional Radiologist, Minimally Invasive Surgical Solutions San Jose, CA
David C. Madoff, MD, FSIR, FACR

David C. Madoff, MD, FSIR, FACR

Professor of Radiology Vice Chairman of Academic Affairs Weill Cornell Medical College New York, NY
Menu